# RWE of 1st Line Treatment With ATO/ATRA for Adult APL

> **NCT04897490** · — · RECRUITING · sponsor: **Grupo Argentino de Tratamiento de la Leucemia Aguda** · enrollment: 50 (estimated)

## Conditions studied

- Promyelocytic Leukemia, Adult Acute

## Interventions

- **OTHER:** Evaluation of first line treatment with ATO/ATRA outcome

## Key facts

- **NCT ID:** NCT04897490
- **Lead sponsor:** Grupo Argentino de Tratamiento de la Leucemia Aguda
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-01
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04897490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04897490, "RWE of 1st Line Treatment With ATO/ATRA for Adult APL". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04897490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*